• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA Lnc-Tim3 通过与 Tim-3 结合并诱导 Bat3 的核转位在 HCC 中加重 CD8 T 细胞耗竭。

Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC.

机构信息

Liver Transplantation Center of the First Affiliated Hospital and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu Province, China.

Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.

出版信息

Cell Death Dis. 2018 May 1;9(5):478. doi: 10.1038/s41419-018-0528-7.

DOI:10.1038/s41419-018-0528-7
PMID:29706626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5924754/
Abstract

Although one of the first comprehensive examinations of long non-coding RNA (lncRNA) expression was performed in human CD8 T lymphocytes, little is known about their roles in CD8 T cells functions during the progression of hepatocellular carcinoma (HCC). Here, we show that Lnc-Tim3 is upregulated and negatively correlates with IFN-γ and IL-2 production in tumor-infiltrating CD8 T cells of HCC patients. Lnc-Tim3 plays a pivotal role in stimulating CD8 T exhaustion and the survival of the exhausted CD8 T cells. Mechanistically, Lnc-Tim3 specifically binds to Tim-3 and blocks its interaction with Bat3, thus suppressing downstream Lck/ NFAT1/AP-1 signaling, leading to nuclear localization of Bat3, and enhancing p300-dependent p53 and RelA transcriptional activation of anti-apoptosis genes including MDM2 and Bcl-2. In summary, Lnc-Tim3 promotes T cell exhaustion, a phenotype which is correlated with compromised anti-tumor immunity, suggesting that Lnc-Tim3 and its associated signaling pathways may influence the outcome of cancer therapies aimed at modulating the acquired immune system.

摘要

尽管最早对长非编码 RNA (lncRNA) 表达的全面研究之一是在人类 CD8 T 淋巴细胞中进行的,但对于它们在肝癌 (HCC) 进展过程中 CD8 T 细胞功能中的作用知之甚少。在这里,我们表明 Lnc-Tim3 在 HCC 患者肿瘤浸润性 CD8 T 细胞中上调,并与 IFN-γ 和 IL-2 的产生呈负相关。Lnc-Tim3 在刺激 CD8 T 耗竭和耗竭的 CD8 T 细胞的存活中起着关键作用。在机制上,Lnc-Tim3 特异性结合 Tim-3 并阻断其与 Bat3 的相互作用,从而抑制下游 Lck/NFAT1/AP-1 信号传导,导致 Bat3 的核定位,并增强 p300 依赖性 p53 和 RelA 转录激活包括 MDM2 和 Bcl-2 在内的抗凋亡基因。总之,Lnc-Tim3 促进了 T 细胞耗竭,这种表型与抗肿瘤免疫受损相关,表明 Lnc-Tim3 及其相关信号通路可能影响旨在调节获得性免疫系统的癌症治疗的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/cb5d3d2bb264/41419_2018_528_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/79e241735219/41419_2018_528_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/d65d4bae2eb0/41419_2018_528_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/eadf2ba79c4f/41419_2018_528_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/3372c01d251a/41419_2018_528_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/2cddb38d9d42/41419_2018_528_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/cb5d3d2bb264/41419_2018_528_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/79e241735219/41419_2018_528_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/d65d4bae2eb0/41419_2018_528_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/eadf2ba79c4f/41419_2018_528_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/3372c01d251a/41419_2018_528_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/2cddb38d9d42/41419_2018_528_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9779/5924754/cb5d3d2bb264/41419_2018_528_Fig6_HTML.jpg

相似文献

1
Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC.长非编码 RNA Lnc-Tim3 通过与 Tim-3 结合并诱导 Bat3 的核转位在 HCC 中加重 CD8 T 细胞耗竭。
Cell Death Dis. 2018 May 1;9(5):478. doi: 10.1038/s41419-018-0528-7.
2
Repression of CRNDE enhances the anti-tumour activity of CD8 + T cells against oral squamous cell carcinoma through regulating miR-545-5p and TIM-3.抑制 CRNDE 通过调控 miR-545-5p 和 TIM-3 增强 CD8+T 细胞对口腔鳞状细胞癌的抗肿瘤活性。
J Cell Mol Med. 2021 Dec;25(23):10857-10868. doi: 10.1111/jcmm.16909. Epub 2021 Nov 2.
3
Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.阻断Tim-3或/和PD-1可逆转HBV相关肝细胞癌中肿瘤浸润淋巴细胞的功能障碍。
Bull Cancer. 2018 May;105(5):493-501. doi: 10.1016/j.bulcan.2018.01.018. Epub 2018 Mar 22.
4
Repression of lncRNA NEAT1 enhances the antitumor activity of CD8T cells against hepatocellular carcinoma via regulating miR-155/Tim-3.抑制长链非编码 RNA NEAT1 通过调节 miR-155/Tim-3 增强 CD8T 细胞对肝癌的抗肿瘤活性。
Int J Biochem Cell Biol. 2019 May;110:1-8. doi: 10.1016/j.biocel.2019.01.019. Epub 2019 Jan 30.
5
PD1 CD8 T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma.PD1 CD8 T 细胞与肝癌衰竭特征和不良临床结局相关。
J Immunother Cancer. 2019 Nov 29;7(1):331. doi: 10.1186/s40425-019-0814-7.
6
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion.长链非编码 RNA lnc-EGFR 刺激调节性 T 细胞分化,从而促进肝癌的免疫逃逸。
Nat Commun. 2017 May 25;8:15129. doi: 10.1038/ncomms15129.
7
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8 T Cells and Features of Hepatocellular Carcinoma.肿瘤浸润 CD8 T 细胞中 PD1 的表达水平与肝细胞癌特征的关系。
Gastroenterology. 2018 Dec;155(6):1936-1950.e17. doi: 10.1053/j.gastro.2018.08.030. Epub 2018 Aug 24.
8
PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.PD-1+ Tim3+ 肿瘤浸润性 CD8 T 细胞维持了产生 IFN-γ 的潜力,但在卵巢癌中丧失了细胞毒性活性。
Int Immunol. 2020 May 30;32(6):397-405. doi: 10.1093/intimm/dxaa010.
9
TOX promotes the exhaustion of antitumor CD8 T cells by preventing PD1 degradation in hepatocellular carcinoma.TOX 通过阻止 PD1 降解促进肝癌中抗肿瘤 CD8 T 细胞耗竭。
J Hepatol. 2019 Oct;71(4):731-741. doi: 10.1016/j.jhep.2019.05.015. Epub 2019 Jun 5.
10
Combination therapy with anti-T-cell immunoglobulin and mucin-domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma.抗 T 细胞免疫球蛋白和粘蛋白结构域包含分子 3 与放射联合治疗可提高小鼠肝癌的抗肿瘤疗效。
J Gastroenterol Hepatol. 2021 May;36(5):1357-1365. doi: 10.1111/jgh.15319. Epub 2021 Jan 7.

引用本文的文献

1
Characterization of Cuproptosis-Related LncRNAs Prognostic Signature and Identification of LINC02285 as a Novel Biomarker for Ovarian Cancer.铜死亡相关长链非编码RNA预后特征的表征及LINC02285作为卵巢癌新型生物标志物的鉴定
J Inflamm Res. 2025 Jun 8;18:7419-7442. doi: 10.2147/JIR.S521410. eCollection 2025.
2
Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy.长链非编码RNA作为肝细胞癌免疫微环境的关键调节因子:对免疫治疗的启示
Front Immunol. 2025 Apr 25;16:1523190. doi: 10.3389/fimmu.2025.1523190. eCollection 2025.
3
Deciphering the mechanisms of long non-coding RNAs in ferroptosis: insights into its clinical significance in cancer progression and immunology.

本文引用的文献

1
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.不同的细胞机制是抗CTLA-4和抗PD-1检查点阻断的基础。
Cell. 2017 Sep 7;170(6):1120-1133.e17. doi: 10.1016/j.cell.2017.07.024. Epub 2017 Aug 10.
2
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.针对免疫检查点分子的抗体恢复了肝癌浸润 T 细胞的功能。
Gastroenterology. 2017 Oct;153(4):1107-1119.e10. doi: 10.1053/j.gastro.2017.06.017. Epub 2017 Jun 23.
3
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion.
解读长链非编码RNA在铁死亡中的作用机制:深入了解其在癌症进展和免疫学中的临床意义。
Cell Death Discov. 2025 Jan 18;11(1):14. doi: 10.1038/s41420-025-02290-6.
4
Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy.肝细胞癌微环境的空间异质性决定免疫治疗的疗效。
Discov Oncol. 2025 Jan 7;16(1):15. doi: 10.1007/s12672-025-01747-5.
5
CAF-EVs carry lncRNA MAPKAPK5-AS1 into hepatocellular carcinoma cells and promote malignant cell proliferation.癌相关成纤维细胞衍生的细胞外囊泡将长链非编码RNA MAPKAPK5-AS1转运至肝癌细胞中并促进恶性细胞增殖。
Commun Biol. 2024 Dec 30;7(1):1711. doi: 10.1038/s42003-024-07428-3.
6
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review).乐伐替尼在晚期肝细胞癌中的临床应用作用及其耐药机制(综述)
Am J Cancer Res. 2024 Sep 15;14(9):4113-4171. doi: 10.62347/UJVP4361. eCollection 2024.
7
Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma.用于肝细胞癌预后预测的五个坏死性凋亡相关长链非编码RNA特征的鉴定与验证
Heliyon. 2024 Sep 6;10(18):e37403. doi: 10.1016/j.heliyon.2024.e37403. eCollection 2024 Sep 30.
8
Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review.探索长链非编码 RNA 在癌症免疫治疗中的潜在作用:全面综述。
Front Immunol. 2024 Aug 27;15:1446937. doi: 10.3389/fimmu.2024.1446937. eCollection 2024.
9
LncRNAs in Immune and Stromal Cells Remodel Phenotype of Cancer Cell and Tumor Microenvironment.免疫细胞和基质细胞中的长链非编码RNA重塑癌细胞表型和肿瘤微环境。
J Inflamm Res. 2024 May 17;17:3173-3185. doi: 10.2147/JIR.S460730. eCollection 2024.
10
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells.TIM-3、LAG-3 或 2B4 基因敲除可增强工程化 T 细胞的抗肿瘤反应。
Front Immunol. 2024 Feb 29;15:1315283. doi: 10.3389/fimmu.2024.1315283. eCollection 2024.
长链非编码 RNA lnc-EGFR 刺激调节性 T 细胞分化,从而促进肝癌的免疫逃逸。
Nat Commun. 2017 May 25;8:15129. doi: 10.1038/ncomms15129.
4
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.TIM-3作为癌症免疫治疗的靶点及作用机制
Int J Mol Sci. 2017 Mar 16;18(3):645. doi: 10.3390/ijms18030645.
5
Tim-3 and its role in regulating anti-tumor immunity.Tim-3及其在调节抗肿瘤免疫中的作用。
Immunol Rev. 2017 Mar;276(1):97-111. doi: 10.1111/imr.12520.
6
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.淋巴细胞激活基因-3、T细胞免疫球蛋白黏蛋白-3和T细胞免疫受体Ig和ITIM结构域:在免疫调节中具有特殊功能的共抑制受体。
Immunity. 2016 May 17;44(5):989-1004. doi: 10.1016/j.immuni.2016.05.001.
7
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.BCL-2 三十年:将细胞死亡发现转化为新型癌症疗法。
Nat Rev Cancer. 2016 Feb;16(2):99-109. doi: 10.1038/nrc.2015.17.
8
Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression.lncRNA-mRNA共表达模式的综合分析鉴定出卵巢癌恶性进展中与免疫相关的lncRNA生物标志物。
Sci Rep. 2015 Dec 3;5:17683. doi: 10.1038/srep17683.
9
Long noncoding RNAs in T lymphocytes.T淋巴细胞中的长链非编码RNA
J Leukoc Biol. 2016 Jan;99(1):31-44. doi: 10.1189/jlb.1RI0815-389R. Epub 2015 Nov 4.
10
Immunological landscape and immunotherapy of hepatocellular carcinoma.肝细胞癌的免疫景观和免疫疗法。
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):681-700. doi: 10.1038/nrgastro.2015.173. Epub 2015 Oct 20.